Cardinal Health, Inc. $CAH is Sivik Global Healthcare LLC’s 9th Largest Position

Sivik Global Healthcare LLC cut its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 10.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 45,000 shares of the company’s stock after selling 5,000 shares during the period. Cardinal Health makes up 2.1% of Sivik Global Healthcare LLC’s investment portfolio, making the stock its 9th biggest holding. Sivik Global Healthcare LLC’s holdings in Cardinal Health were worth $7,560,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CAH. JPMorgan Chase & Co. raised its stake in shares of Cardinal Health by 40.0% during the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after buying an additional 1,193,983 shares in the last quarter. Northern Trust Corp raised its stake in shares of Cardinal Health by 3.5% during the 1st quarter. Northern Trust Corp now owns 3,143,003 shares of the company’s stock worth $433,012,000 after buying an additional 105,154 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Cardinal Health by 1,666.7% during the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after buying an additional 2,249,241 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Cardinal Health by 3.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company’s stock worth $227,877,000 after buying an additional 52,714 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of Cardinal Health by 0.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,246,788 shares of the company’s stock worth $171,749,000 after buying an additional 7,940 shares in the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CAH has been the subject of a number of analyst reports. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. UBS Group reissued a “buy” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Wells Fargo & Company reissued an “overweight” rating and set a $185.00 target price (up from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Robert W. Baird increased their target price on Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 13th. Finally, Argus set a $189.00 price target on Cardinal Health in a report on Friday, August 22nd. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average price target of $166.00.

Cardinal Health Price Performance

CAH opened at $156.86 on Friday. The stock has a market cap of $37.27 billion, a P/E ratio of 24.32, a P/E/G ratio of 1.33 and a beta of 0.71. The stock’s 50 day simple moving average is $152.09 and its 200 day simple moving average is $151.21. Cardinal Health, Inc. has a 1-year low of $106.98 and a 1-year high of $168.44.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. The business had revenue of $60.16 billion for the quarter, compared to analysts’ expectations of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company’s revenue was up .5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s dividend payout ratio is 31.63%.

Insider Activity

In other Cardinal Health news, insider Jessica L. Mayer sold 38,078 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the sale, the insider owned 48,457 shares in the company, valued at approximately $7,211,370.74. This represents a 44.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Stephen M. Mason sold 41,575 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $6,187,191.50. Following the sale, the chief executive officer owned 26,085 shares in the company, valued at approximately $3,881,969.70. This trade represents a 61.45% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock worth $40,489,525 in the last quarter. 0.12% of the stock is currently owned by corporate insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.